Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Bacterial Infections
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Bacterial Infections
    Risk of TB Higher for Patients Taking Infliximab, Adalimumab, Than Etanercept - (DGNews)
    Presence of Panton-Valentine Leukocidin in MSSA Not Only Factor in Assessing Disease Severity: Presented at ICC - (DGDispatch)
    TopAbstracts in Bacterial Infections 06/22/2009 - (DGNews)
    Use of Assay Can Detect Lower Genital Tract Infections in Patients With Neisseria gonorrhoeae: Presented at ICC - (DGDispatch)
    Proton Pump Inhibitors May Increase Risk for Clostridium difficile Outbreaks: Presented at ICC - (DGDispatch)

    News archive

     Recent webcasts/CME - Bacterial Infections
      Peritoneal Tuberculosis: Modern Peril for an Ancient Disease
      Actinomycosis: Diagnosis and Management
      Infectious Complications of Biologic Therapies: Preventive and Therapeutic Strategies
      Relative Risks of Serious Bacterial and Opportunistic Infections Among Biologics: Results of Randomized Trials and Observational Studies
      Importance of Assessing Immunocompetence in Biologic Drug Development

      Webcasts/CME archive

       Recent cases - Bacterial Infections
        An Adult Case of Urinary Tract Infection with Kingella Kingae: A Case Report
        Infectious Arthritis of the Knee Caused by Mycobacterium Terrae: A Case Report
        Generalized Tetanus in a 4-Year Old Boy Presenting with Dysphagia and Trismus: A Case Report
        Single Lesion Multibacillary Leprosy, a Treatment Enigma: A Case Report
        Lemierre's Syndrome, Reemergence of a Forgotten Disease: A Case Report

        Cases archive
          




        my personal edition > bacterial infections > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Topical Antibiotics Reduce Postoperative Infections In Staphylococcus aureus Carriers

        A DGReview of :"Intranasal Mupirocin to Prevent Postoperative Staphylococcus aureus Infections"
        New England Journal of Medicine (NEJM)

        06/13/2002
        By Elda Hauschildt


        Topical antibiotic treatment is effective in reducing the rate of Staphylococcus aureus infections at surgical sites in a subgroup of patients who are nasal carriers of S. aureus.

        Researchers from the University of Iowa in Iowa City and the Johns Hopkins Medical Institutions in Baltimore, Maryland, United States, say prophylactic intranasal application of mupirocin did not significantly reduce the rate of S. aureus surgical-site infections overall. However, this randomised, double-blind placebo-controlled trial indicated found that prophylactic use significantly decreased the rate of all nosocomial infections among patients who are S. aureus carriers.

        They state: "We conclude that mupirocin therapy is safe, has a protective effect among nasal carriers of S. aureus and is a reasonable adjuvant agent to prevent such infections in carriers after surgery."

        Study participants involved 4,030 patients undergoing general, gynaecologic, neurologic or cardiothoracic surgery, 3,864 were included in intention-to-treat analysis.

        Overall, 2.3 percent of patients receiving mupirocin and 2.4 of those receiving placebo developed S. aureus infections at surgical sites.

        A total of 891 participants (23.1 percent of those completing the study) had S. aureus in their anterior nares. Researchers randomised 444 of these patients to mupirocin and 447 to placebo.

        Among these patients, 4.0 percent of those receiving mupirocin had nosocomial S. aureus infections, compared with 7.7 percent of those who received placebo.

        Investigators note that there is a concern that prophylactic use of mupirocin could lead to widespread resistance: "Using the short and defined course of mupirocin prescribed by the protocol, we identified only four isolates that were resistant to mupirocin, three of which were obtained from patients who were not treated by mupirocin.

        "Thus, a single, short course of mupirocin for preoperative prophylaxis did not appear to select for mupirocin-resistant S. aureus isolates."
        NEJM, 2002; 346: 1871-1877. "Intranasal Mupirocin to Prevent Postoperative Staphylococcus aureus Infections"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send